# Trade Mark Journal No.2026/029 17 July 2026

## WO0000001925341 (44)

Office of origin: United States of America

Date of International Registration:2 June 2026
Date of designation in the UK: 2 June 2026

International priority date claimed: 19 December 2025 (United States of America) (99558371)

Class 44
  Providing medical information in the field of multiple myeloma.

Kite Pharma, Inc.

Representative: CYNTHIA SMUZYNSKA Gilead Sciences, Inc., 333 LAKESIDE DRIVE, FOSTER CITY CA 94404, UNITED STATES OF AMERICA